These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 4275226)
1. Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas. Karney W; Holmes KK; Turck M Antimicrob Agents Chemother; 1973 Mar; 3(3):338-42. PubMed ID: 4275226 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin. Yourassowsky E; Schoutens E; Vanderlinden MP Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457 [TBL] [Abstract][Full Text] [Related]
3. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin. Reynolds AV; Hamilton-Miller JM; Brumfitt W Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265 [TBL] [Abstract][Full Text] [Related]
4. Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics. Price KE; Pursiano TA; DeFuria MD Antimicrob Agents Chemother; 1974 Feb; 5(2):143-52. PubMed ID: 4209522 [TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics. Meyer RD; Draus LL; Pasieczinik KA Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036 [TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin. Yu PK; Washington JA Antimicrob Agents Chemother; 1973 Aug; 4(2):133-9. PubMed ID: 4208506 [TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin. Ries K; Levison ME; Kaye D Antimicrob Agents Chemother; 1973 Apr; 3(4):532-3. PubMed ID: 4790607 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics. Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591 [TBL] [Abstract][Full Text] [Related]
9. Tobramycin: in vitro activity and comparison with kanamycin and gentamicin. Del Bene VE; Farrar WE Antimicrob Agents Chemother; 1972 Apr; 1(4):340-2. PubMed ID: 4670697 [TBL] [Abstract][Full Text] [Related]
10. In vitro studies of BB-K8, a new aminoglycoside antibiotic. Bodey GP; Stewart D Antimicrob Agents Chemother; 1973 Aug; 4(2):186-92. PubMed ID: 4790938 [TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)]. Schassan HH Infection; 1976; 4(2):35-41. PubMed ID: 789246 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides. Watanakunakorn C; Kauffman CA Infection; 1978; 6(3):111-5. PubMed ID: 98451 [TBL] [Abstract][Full Text] [Related]
13. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae. Briedis DJ; Robson HG Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032 [TBL] [Abstract][Full Text] [Related]
14. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics. Kabins SA; Nathan C; Cohen S Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021 [TBL] [Abstract][Full Text] [Related]
15. In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8. Levison ME; Kaye D Antimicrob Agents Chemother; 1974 Jun; 5(6):667-9. PubMed ID: 15825423 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates. Stewart D; Bodey GP J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of Sch 20656, netilmicin, gentamicin, and tobramycin. Watanakunakorn C Antimicrob Agents Chemother; 1976 Aug; 10(2):382-3. PubMed ID: 825025 [TBL] [Abstract][Full Text] [Related]
18. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media. Digranes A; Dibb WL; Benonisen E; Ostervold B Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of "enterobacteria" to aminoglycoside antibiotics: comparisons with tetracyclines, polymyxins, chloramphenicol, and spectinomycin. Finland M; Garner C; Wilcox C; Sabath LD J Infect Dis; 1976 Aug; 134 Suppl():S57-74. PubMed ID: 184213 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods. Klastersky J; Nyamubeya B; Vandenborre L J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836 [No Abstract] [Full Text] [Related] [Next] [New Search]